Emulsi Biotech

1. 02 Sep 2026

   Funding round

   —

   Cumulative —

Amounts in EUR, converted at the ECB rate on the event date. Funding totals exclude debt, grants and state aid; rounds whose instrument is not yet established are still counted. Every figure links to its source.

• Funding02 Sep 2026

  Emulsi Biotech has completed its first funding round.

  ▸Source: Rapidus

  “Smile-bolaget Emulsi Biotech, med vd Eimantas Gladkauskas, utvecklar en revolutionerande metod för att administrera biologiska läkemedel. Nyligen gjorde bolaget sin första runda och startar nu de…”

  Read at Rapidus

• Eimantas Gladkauskas

  CEO

What does Emulsi Biotech do?

Emulsi Biotech is developing a revolutionary method for administering biological drugs.

Where is Emulsi Biotech headquartered?

Emulsi Biotech is based in Lithuania.

What was Emulsi Biotech's latest funding round?

Emulsi Biotech's most recent disclosed round was a funding round, announced 2 September 2026.